Rane (Madras) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:34 am

Competitors of Rane (Madras) Ltd

All Competitor Stocks of Rane (Madras) Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:40 am

Below is a detailed analysis of the quarterly data for Rane (Madras) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 881.00 Cr.. The value appears to be declining and may need further review. It has decreased from 901.00 Cr. (Mar 2025) to 881.00 Cr., marking a decrease of 20.00 Cr..
• For Expenses, as of Jun 2025, the value is 806.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 823.00 Cr. (Mar 2025) to 806.00 Cr., marking a decrease of 17.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 75.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 75.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 17.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 36.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 62.00% (Mar 2025) to 25.00%, marking a decrease of 37.00%.
• For Net Profit, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.70. The value appears strong and on an upward trend. It has increased from 4.01 (Mar 2025) to 6.70, marking an increase of 2.69.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:35 am

Growth

Last Updated: September 5, 2025, 1:00 pm

Balance Sheet

Last Updated: November 9, 2025, 2:48 pm

Below is a detailed analysis of the balance sheet data for Rane (Madras) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 12.00 Cr..
• For Reserves, as of Sep 2025, the value is 652.00 Cr.. The value appears to be declining and may need further review. It has decreased from 655.00 Cr. (Mar 2025) to 652.00 Cr., marking a decrease of 3.00 Cr..
• For Borrowings, as of Sep 2025, the value is 832.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 813.00 Cr. (Mar 2025) to 832.00 Cr., marking an increase of 19.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 898.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 785.00 Cr. (Mar 2025) to 898.00 Cr., marking an increase of 113.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,411.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,269.00 Cr. (Mar 2025) to 2,411.00 Cr., marking an increase of 142.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 680.00 Cr.. The value appears to be declining and may need further review. It has decreased from 693.00 Cr. (Mar 2025) to 680.00 Cr., marking a decrease of 13.00 Cr..
• For CWIP, as of Sep 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2025) to 97.00 Cr., marking an increase of 24.00 Cr..
• For Investments, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,626.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,496.00 Cr. (Mar 2025) to 1,626.00 Cr., marking an increase of 130.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,411.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,269.00 Cr. (Mar 2025) to 2,411.00 Cr., marking an increase of 142.00 Cr..

However, the Borrowings (832.00 Cr.) are higher than the Reserves (652.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Rane (Madras) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 13.62. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 13.62, marking an increase of 11.77.
• For Diluted EPS (Rs.), as of Mar 25, the value is 13.62. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 13.62, marking an increase of 11.77.
• For Cash EPS (Rs.), as of Mar 25, the value is 104.47. This value is within the healthy range. It has increased from 57.81 (Mar 24) to 104.47, marking an increase of 46.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.36. It has increased from 157.32 (Mar 24) to 405.36, marking an increase of 248.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.36. It has increased from 157.32 (Mar 24) to 405.36, marking an increase of 248.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,093.27. It has increased from 1,376.12 (Mar 24) to 2,093.27, marking an increase of 717.15.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 183.01. This value is within the healthy range. It has increased from 92.62 (Mar 24) to 183.01, marking an increase of 90.39.
• For PBIT / Share (Rs.), as of Mar 25, the value is 101.68. This value is within the healthy range. It has increased from 36.67 (Mar 24) to 101.68, marking an increase of 65.01.
• For PBT / Share (Rs.), as of Mar 25, the value is 47.88. This value is within the healthy range. It has increased from -63.01 (Mar 24) to 47.88, marking an increase of 110.89.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 23.14, marking an increase of 21.28.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 23.14, marking an increase of 21.28.
• For PBDIT Margin (%), as of Mar 25, the value is 8.74. This value is below the healthy minimum of 10. It has increased from 6.73 (Mar 24) to 8.74, marking an increase of 2.01.
• For PBIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from 2.66 (Mar 24) to 4.85, marking an increase of 2.19.
• For PBT Margin (%), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 10. It has increased from -4.57 (Mar 24) to 2.28, marking an increase of 6.85.
• For Net Profit Margin (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 1.10, marking an increase of 0.97.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 8. It has increased from 0.13 (Mar 24) to 1.10, marking an increase of 0.97.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.70. This value is below the healthy minimum of 15. It has increased from 1.17 (Mar 24) to 5.70, marking an increase of 4.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 17.23, marking an increase of 6.46.
• For Return On Assets (%), as of Mar 25, the value is 1.65. This value is below the healthy minimum of 5. It has increased from 0.22 (Mar 24) to 1.65, marking an increase of 1.43.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 1.02 (Mar 24) to 0.32, marking a decrease of 0.70.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.15. This value exceeds the healthy maximum of 1. It has decreased from 2.74 (Mar 24) to 1.15, marking a decrease of 1.59.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has increased from 1.65 (Mar 24) to 1.87, marking an increase of 0.22.
• For Current Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1.5. It has increased from 0.85 (Mar 24) to 0.98, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 24) to 0.65, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.10. This value exceeds the healthy maximum of 8. It has increased from 5.74 (Mar 24) to 10.10, marking an increase of 4.36.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 71.20. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 24) to 71.20, marking an increase of 71.20.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.77. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 15.77, marking an increase of 15.77.
• For Earning Retention Ratio (%), as of Mar 25, the value is 28.80. This value is below the healthy minimum of 40. It has increased from 0.00 (Mar 24) to 28.80, marking an increase of 28.80.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.23. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.23, marking an increase of 84.23.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.99. This value is within the healthy range. It has increased from 2.67 (Mar 24) to 3.99, marking an increase of 1.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.68. This value is below the healthy minimum of 3. It has decreased from 2.93 (Mar 24) to 1.68, marking a decrease of 1.25.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,750.42. It has decreased from 1,796.95 (Mar 24) to 1,750.42, marking a decrease of 46.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.51, marking a decrease of 0.29.
• For EV / EBITDA (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has decreased from 11.92 (Mar 24) to 5.88, marking a decrease of 6.04.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
• For Retention Ratios (%), as of Mar 25, the value is 28.79. This value is below the healthy minimum of 30. It has increased from 0.00 (Mar 24) to 28.79, marking an increase of 28.79.
• For Price / BV (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 4.38 (Mar 24) to 1.55, marking a decrease of 2.83.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness